vs
Side-by-side financial comparison of Danaos Corp (DAC) and Enhabit, Inc. (EHAB). Click either name above to swap in a different company.
Enhabit, Inc. is the larger business by last-quarter revenue ($270.4M vs $262.2M, roughly 1.0× Danaos Corp). Danaos Corp runs the higher net margin — 49.9% vs -14.3%, a 64.2% gap on every dollar of revenue. On growth, Danaos Corp posted the faster year-over-year revenue change (6.4% vs 4.7%).
Danaos Corporation is a leading global containership ownership and management firm. It operates a large fleet of modern container vessels, providing long-term charter services to top international container liner operators across major global trade routes, supporting the efficiency and reliability of global supply chains.
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
DAC vs EHAB — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $262.2M | $270.4M |
| Net Profit | $130.9M | $-38.7M |
| Gross Margin | — | — |
| Operating Margin | 47.9% | -12.3% |
| Net Margin | 49.9% | -14.3% |
| Revenue YoY | 6.4% | 4.7% |
| Net Profit YoY | -7.3% | 15.9% |
| EPS (diluted) | $7.12 | $-0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $270.4M | ||
| Q3 25 | — | $263.6M | ||
| Q2 25 | $262.2M | $266.1M | ||
| Q1 25 | — | $259.9M | ||
| Q4 24 | — | $258.2M | ||
| Q3 24 | — | $253.6M | ||
| Q2 24 | $246.3M | $260.6M | ||
| Q1 24 | — | $262.4M |
| Q4 25 | — | $-38.7M | ||
| Q3 25 | — | $11.1M | ||
| Q2 25 | $130.9M | $5.2M | ||
| Q1 25 | — | $17.8M | ||
| Q4 24 | — | $-46.0M | ||
| Q3 24 | — | $-110.2M | ||
| Q2 24 | $141.2M | $-200.0K | ||
| Q1 24 | — | $200.0K |
| Q4 25 | — | -12.3% | ||
| Q3 25 | — | 6.4% | ||
| Q2 25 | 47.9% | 6.3% | ||
| Q1 25 | — | 6.1% | ||
| Q4 24 | — | -16.0% | ||
| Q3 24 | — | -38.6% | ||
| Q2 24 | 56.8% | 4.3% | ||
| Q1 24 | — | 4.9% |
| Q4 25 | — | -14.3% | ||
| Q3 25 | — | 4.2% | ||
| Q2 25 | 49.9% | 2.0% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | -17.8% | ||
| Q3 24 | — | -43.5% | ||
| Q2 24 | 57.3% | -0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | — | $-0.76 | ||
| Q3 25 | — | $0.22 | ||
| Q2 25 | $7.12 | $0.10 | ||
| Q1 25 | — | $0.35 | ||
| Q4 24 | — | $-0.92 | ||
| Q3 24 | — | $-2.20 | ||
| Q2 24 | $7.23 | $0.00 | ||
| Q1 24 | — | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $654.1M | $43.6M |
| Total DebtLower is stronger | — | $426.0M |
| Stockholders' EquityBook value | $3.6B | $534.0M |
| Total Assets | $4.5B | $1.2B |
| Debt / EquityLower = less leverage | — | 0.80× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $43.6M | ||
| Q3 25 | — | $56.9M | ||
| Q2 25 | $654.1M | $37.1M | ||
| Q1 25 | — | $39.5M | ||
| Q4 24 | — | $28.4M | ||
| Q3 24 | — | $45.7M | ||
| Q2 24 | $471.7M | $28.5M | ||
| Q1 24 | — | $36.5M |
| Q4 25 | — | $426.0M | ||
| Q3 25 | — | $441.5M | ||
| Q2 25 | — | $456.9M | ||
| Q1 25 | — | $467.3M | ||
| Q4 24 | — | $492.6M | ||
| Q3 24 | — | $502.9M | ||
| Q2 24 | — | $512.7M | ||
| Q1 24 | — | $526.7M |
| Q4 25 | — | $534.0M | ||
| Q3 25 | — | $566.8M | ||
| Q2 25 | $3.6B | $552.4M | ||
| Q1 25 | — | $543.2M | ||
| Q4 24 | — | $523.5M | ||
| Q3 24 | — | $566.1M | ||
| Q2 24 | $3.3B | $674.3M | ||
| Q1 24 | — | $672.3M |
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | $4.5B | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | $4.0B | $1.4B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | — | 0.80× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.83× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | — | 0.94× | ||
| Q3 24 | — | 0.89× | ||
| Q2 24 | — | 0.76× | ||
| Q1 24 | — | 0.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $4.4M |
| Free Cash FlowOCF − Capex | — | $3.3M |
| FCF MarginFCF / Revenue | — | 1.2% |
| Capex IntensityCapex / Revenue | — | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $65.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.4M | ||
| Q3 25 | — | $37.8M | ||
| Q2 25 | — | $10.6M | ||
| Q1 25 | — | $17.9M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | — | $28.4M | ||
| Q2 24 | — | $9.6M | ||
| Q1 24 | — | $17.3M |
| Q4 25 | — | $3.3M | ||
| Q3 25 | — | $36.2M | ||
| Q2 25 | — | $8.7M | ||
| Q1 25 | — | $17.6M | ||
| Q4 24 | — | $-4.7M | ||
| Q3 24 | — | $27.7M | ||
| Q2 24 | — | $8.9M | ||
| Q1 24 | — | $15.5M |
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | 13.7% | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | -1.8% | ||
| Q3 24 | — | 10.9% | ||
| Q2 24 | — | 3.4% | ||
| Q1 24 | — | 5.9% |
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 0.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.41× | ||
| Q2 25 | — | 2.04× | ||
| Q1 25 | — | 1.01× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 86.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DAC
Segment breakdown not available.
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
